跳至主要内容
临床试验/CTRI/2019/07/020404
CTRI/2019/07/020404尚未招募未知

A pilot study to estimate prevalence of Celiac disease in high risk-group in Asia (Asian celiac disease Study)

Takeda Pharmaceutical Company Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Age 18-60
  • 2. Both genders
  • 3. Willing to participate
  • 4. Patients with Irritable Bowel Syndrome (IBS) and 5. Functional Dyspepsia (FD) as per Rome IV criteria

排除标准

  • 1. Previously diagnosed cases of celiac disease
  • 2. Patients on Gluten free diet
  • 3. Refusal to provide consent
  • 4. Pregnant women
  • 5. HIV positive patients
  • 6. Chronic NSAID intake
  • 7. Active smoking
  • 8. Inflammatory bowel disease
  • 9. Dysmorphic features and disproportionate short stature
  • 10. Comorbid severe conditions - pulmonary, renal, liver, cardiac, chronic illness and medication

研究者

相似试验